|
ZNF786 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.786400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.736230E-01 |
| Normal-vs-Stage2 |
1.426360E-01 |
| Normal-vs-Stage3 |
2.944100E-02 |
| Normal-vs-Stage4 |
3.861700E-02 |
| Stage1-vs-Stage2 |
5.299000E-01 |
| Stage1-vs-Stage3 |
2.993000E-01 |
| Stage1-vs-Stage4 |
3.506400E-01 |
| Stage2-vs-Stage3 |
9.308400E-01 |
| Stage2-vs-Stage4 |
9.156200E-01 |
| Stage3-vs-Stage4 |
9.737600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.084200E-02 |
| Normal-vs-AfricanAmerican |
3.583600E-01 |
| Normal-vs-Asian |
8.016400E-02 |
| Caucasian-vs-AfricanAmerican |
4.602400E-01 |
| Caucasian-vs-Asian |
1.521810E-02 |
| AfricanAmerican-vs-Asian |
7.422400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.446200E-02 |
| Normal-vs-Female |
2.987200E-01 |
| Male-vs-Female |
9.214100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.224000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.990300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.269640E-01 |
| Normal-vs-Age(81-100Yrs) |
6.207900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.369200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.560000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.742600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.165400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.911400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.601800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.139400E-01 |
| Normal-vs-Grade 2 |
3.021200E-01 |
| Normal-vs-Grade 3 |
9.018300E-03 |
| Normal-vs-Grade 4 |
1.463560E-02 |
| Grade 1-vs-Grade 2 |
1.850050E-01 |
| Grade 1-vs-Grade 3 |
8.598400E-02 |
| Grade 1-vs-Grade 4 |
7.734000E-02 |
| Grade 2-vs-Grade 3 |
4.456300E-02 |
| Grade 2-vs-Grade 4 |
9.063600E-02 |
| Grade 3-vs-Grade 4 |
7.733400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.354200E-01 |
| Normal-vs-ccB subtype |
6.157100E-03 |
| ccA subtype-vs-ccB subtype |
3.879800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.216100E-02 |
| Normal-vs-N1 |
1.312010E-01 |
| N0-vs-N1 |
7.766000E-01 |
|
|
